Edition:
India

Asahi Kasei Corp (3407.T)

3407.T on Tokyo Stock Exchange

1,444JPY
14 Dec 2017
Change (% chg)

¥10 (+0.73%)
Prev Close
¥1,433
Open
¥1,438
Day's High
¥1,452
Day's Low
¥1,433
Volume
3,351,300
Avg. Vol
3,977,600
52-wk High
¥1,533
52-wk Low
¥1,001

Chart for

About

ASAHI KASEI CORPORATION is mainly engaged in chemical business. It has seven business segments. The Chemical segment offers petrochemicals, functional films, functional resins and others. The Textile segment offers synthetic textile and nonwoven fabrics. The Housing segment is engaged in the development and sale of housing, as... (more)

Overall

Beta: 0.74
Market Cap(Mil.): ¥1,944,026.00
Shares Outstanding(Mil.): 1,402.62
Dividend: 12.00
Yield (%): 1.73

Financials

  Industry Sector
P/E (TTM): -- 18.66 16.44
EPS (TTM): -- -- --
ROI: -- 18.45 10.62
ROE: -- 25.76 14.20

Asahi Kasei unit wins $400 million U.S. defense contract -Pentagon

WASHINGTON, Dec 8 Zoll Medical Corp, a unit of Asahi Kasei Corp, has been awarded a $400 million contract for deployable vital signs monitors, the Pentagon said on Friday. (Reporting by Mohammad Zargham; Editing by Eric Beech)

09 Dec 2017

Israel's Atox Bio raises $30 mln in Arix Bioscience-led round

JERUSALEM, Dec 4 Israeli biotech firm Atox Bio said on Monday it raised $30 million to further develop its leading product as a kidney treatment, in a fundraising round led by U.K.-based Arix Bioscience.

04 Dec 2017

BRIEF-Bone Therapeutics and Asahi Kasei sign exclusive license agreement for Preob in Japan

* REG-BONE THERAPEUTICS SA AND ASAHI KASEI SIGN EXCLUSIVE LICENSE AGREEMENT FOR PREOB® IN JAPAN

22 Sep 2017

Earnings vs. Estimates